247(top 1%)
papers
13.6K(top 1%)
citations
53(top 1%)
h-index
113(top 1%)
g-index
264
all documents
14.4K
doc citations
1.7K
citing journals

Top Articles

#TitleJournalYearCitations
1EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016European Urology20171,594
2EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013European Urology20131,053
3European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 UpdateEuropean Urology2019936
4European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 UpdateEuropean Urology2015804
5European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 UpdateEuropean Urology2018627
6European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 UpdateEuropean Urology2021532
7European Guidelines on Upper Tract Urothelial Carcinomas: 2013 UpdateEuropean Urology2013414
8European Guidelines for the Diagnosis and Management of Upper Urinary Tract Urothelial Cell Carcinomas: 2011 UpdateEuropean Urology2011345
9Tumor-associated copy number changes in the circulation of patients with prostate cancer identified through whole-genome sequencingGenome Medicine2013306
10Prognostic Factors and Predictive Models in Renal Cell Carcinoma: A Contemporary ReviewEuropean Urology2011272
11Oncologic Outcomes of Kidney-sparing Surgery Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the EAU Non-muscle Invasive Bladder Cancer Guidelines PanelEuropean Urology2016215
12Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomyCancer2005207
13Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non–muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic ReviewEuropean Urology2017205
14European Association of Urology (EAU) Prognostic Factor Risk Groups for Non–muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines PanelEuropean Urology2021198
15Contemporary Role of Prostate Cancer Antigen 3 in the Management of Prostate CancerEuropean Urology2011148
16External Validation of the Mayo Clinic Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear-Cell Renal Cell Carcinoma in a Single European Centre Applying Routine PathologyEuropean Urology2010142
17Whole-genome plasma sequencing reveals focal amplifications as a driving force in metastatic prostate cancerNature Communications2016134
18EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†European Urology2020132
19Critical Assessment of Preoperative Urinary Prostate Cancer Antigen 3 on the Accuracy of Prostate Cancer StagingEuropean Urology2011127
20High plasma fibrinogen level represents an independent negative prognostic factor regarding cancer-specific, metastasis-free, as well as overall survival in a European cohort of non-metastatic renal cell carcinoma patientsBritish Journal of Cancer2013117
21Prognostic ability of simplified nuclear grading of renal cell carcinomaCancer2007115
22Grading of Urothelial Carcinoma and The New “World Health Organisation Classification of Tumours of the Urinary System and Male Genital Organs 2016”European Urology Focus2019112
23The Preoperative AST/ALT (De Ritis) Ratio Represents a Poor Prognostic Factor in a Cohort of Patients with Nonmetastatic Renal Cell CarcinomaJournal of Urology2015105
24Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic ReviewEuropean Urology Focus2019103
25External Validation of Urinary PCA3-Based Nomograms to Individually Predict Prostate Biopsy OutcomeEuropean Urology201096
26EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines CommitteesAnnals of Oncology201996
27Prognostic factors for upper urinary tract urothelial carcinomaNature Reviews Urology201194
28Renal Cell Carcinoma with Nodal Metastases in the Absence of Distant Metastatic Disease: Prognostic Indicators of Disease-Specific SurvivalEuropean Urology200793
29Features Associated with Recurrence Beyond 5 Years After Nephrectomy and Nephron-Sparing Surgery for Renal Cell Carcinoma: Development and Internal Validation of a Risk Model (PRELANE score) to Predict Late Recurrence Based on a Large Multicenter Database (CORONA/SATURN Project)European Urology201391
30Prognostic Relevance of Tumour Size in T3a Renal Cell Carcinoma: A Multicentre ExperienceEuropean Urology200787
31pT classification, grade, and vascular invasion as prognostic indicators in urothelial carcinoma of the upper urinary tractModern Pathology200684
32Accuracy of 3-Tesla magnetic resonance imaging for the staging of prostate cancer in comparison to the partin tablesActa Radiologica200983
33Low preoperative lymphocyte-monocyte ratio (LMR) represents a potentially poor prognostic factor in nonmetastatic clear cell renal cell carcinomaUrologic Oncology: Seminars and Original Investigations201482
34Early results of a European multicentre experience with a new self‐anchoring adjustable transobturator system for treatment of stress urinary incontinence in menBJU International201381
35Histologic Tumor Necrosis Is an Independent Prognostic Indicator for Clear Cell and Papillary Renal Cell CarcinomaAmerican Journal of Clinical Pathology201277
36Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate CancerInternational Journal of Molecular Sciences201777
37Tumor Necrosis as Prognostic Indicator in Transitional Cell Carcinoma of the Upper Urinary TractJournal of Urology200676
38Impact of Histologic Subtype on Cancer-specific Survival in Patients with Renal Cell Carcinoma and Tumor ThrombusEuropean Urology201476
39Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non–muscle-invasive Bladder CancerEuropean Urology Focus201974
40Patients with renal cell carcinoma nodal metastases can be accurately identified: External validation of a new nomogramInternational Journal of Cancer200772
41Risk Stratification Tools and Prognostic Models in Non–muscle-invasive Bladder Cancer: A Critical Assessment from the European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines PanelEuropean Urology Focus202072
42Time to recurrence is a significant predictor of cancer‐specific survival after recurrence in patients with recurrent renal cell carcinoma – results from a comprehensive multi‐centre database (CORONA/SATURN‐Project)BJU International201369
43External Validation of the Leibovich Prognosis Score for Nonmetastatic Clear Cell Renal Cell Carcinoma at a Single European Center Applying Routine PathologyJournal of Urology201168
44Validation of the pretreatment derived neutrophil–lymphocyte ratio as a prognostic factor in a European cohort of patients with upper tract urothelial carcinomaBritish Journal of Cancer201466
45Current Insights into Long Non-Coding RNAs in Renal Cell CarcinomaInternational Journal of Molecular Sciences201666
46Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumorsGenome Medicine202066
47Chronological age is not an independent predictor of clinical outcomes after radical nephroureterectomyWorld Journal of Urology201162
48Current Status of Long Non-Coding RNAs in Human Breast CancerInternational Journal of Molecular Sciences201662
49Impact of Resection Technique on Perioperative Outcomes and Surgical Margins after Partial Nephrectomy for Localized Renal Masses: A Prospective Multicenter StudyJournal of Urology202061
50Chromophobe renal cell carcinoma: Comprehensive analysis of 104 cases from multicenter European databaseUrology200560